Reply to: No Evidence that Glucosylsphingosine Is a Biomarker for Parkinson Disease

Mov Disord. 2022 Mar;37(3):654. doi: 10.1002/mds.28936. Epub 2022 Jan 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers
  • Glucosylceramidase
  • Humans
  • Parkinson Disease* / diagnosis
  • Psychosine / analogs & derivatives

Substances

  • Biomarkers
  • Psychosine
  • sphingosyl beta-glucoside
  • Glucosylceramidase